Ugeskrift for laeger 2013-01-28

[Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment].

Morten Blaabjerg, Dragan Marjanovic

Index: Ugeskr. Laeg. 175(5) , 285-6, (2013)

Full Text: HTML

Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare, but treatable lipid storage disorder caused by mutation in the CYP27A1 gene. The disorder results in deposition of cholestanol in various tissues. The classical CTX phenotype includes diarrhoea, juvenile cataract, xanthoma and progressive neurological symptoms. Studies have shown that progression of symptoms can be halted or even reversed, if treatment with chenodeoxycholic acid is initiated early. The diagnosis of CTX is often delayed due to lack of awareness of the disease. We describe the history, clinical features, biochemical, genetic and magnetic resonance imaging findings of the first reported case of CTX in Denmark.